NDC 0143-9721-01 - Levofloxacin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9721
- Requested NDC
- 0143-9721-01
- Package NDCs from labels
- 0143-9721-01, 0143-9721-24
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2019-03-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levofloxacin - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2019-03-28 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9721-01 | Levofloxacin | 100 mL in 1 BAG | INJECTION, SOLUTION | 100 | 12 | |
| 0143-9721-24 | Levofloxacin | 24 in 1 CARTON | INJECTION, SOLUTION | 24 | 12 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9721-01 | ML - Milliliter | 0143-9721 | 4f7ffbd1-d911-4ec3-b828-3cd7ff9fc0f7 | 1 | 2013-02-13 |
| 0143-9721-24 | ML - Milliliter | 0143-9721 | 1d2bf451-0858-4573-afa9-f7bf8356056c | 1 | 2013-12-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVOFLOXACIN | ACTIVE INGREDIENT | 6GNT3Y5LMF | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| LEVOFLOXACIN ANHYDROUS | ACTIVE MOIETY | RIX4E89Y14 | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | LEVOFLOXACIN INJECTION, SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | LX22YL083G |
| Levofloxacin | LEVOFLOXACIN | Cardinal Health 107, LLC | 070375be-3b67-4299-ae8f-4a7b157ac16f | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643bc58-bb0e-5c79-e053-2991aa0a02ae | 2026-05-19 | Warnings | QTT17582CB |
| Levofloxacin | LEVOFLOXACIN | Preferred Pharmaceuticals, Inc. | bcad1dad-53aa-43dd-90f3-cc17cc9598d5 | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Levofloxacin | LEVOFLOXACIN | Preferred Pharmaceuticals, Inc. | 2a8676a9-247f-4fdb-b644-e9785d98771f | 2026-05-19 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Dextrose | DEXTROSE | B. Braun Medical Inc. | 60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5 | 2026-05-12 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | LX22YL083G |
| LEVOFLOXACIN | LEVOFLOXACIN | DIRECT RX | 4f40d5fa-ebcc-516c-e054-00144ff8d46c | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 40fd1ac4-39bb-45fb-ba99-4fb65481f231 | 2026-04-09 | Warnings, Adverse reactions | LX22YL083G |
| Levofloxacin | LEVOFLOXACIN | PD-Rx Pharmaceuticals, Inc. | a5ae33ad-4703-4cb2-8618-6439c906be99 | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | LX22YL083G |
| DEXTROSE | DEXTROSE | HF Acquisition Co. LLC. DBA HealthFirst | 4d2d3d3d-d96e-4005-e063-6394a90afd9a | 2026-03-16 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 3b8f2692-4371-4f1a-95af-b41842131fdd | 2026-03-13 | Warnings, Adverse reactions | LX22YL083G |
| Skin Irritations and Itch Relief | AGARICUS MUSCARIUS, ALUMINA, ANAGALLIS ARVENSIS, ANTIMONIUM TARTARICUM, APIS MELLIFICA, ARSENICUM ALBUM, ARSENICUM IODATUM, BOVISTA, CAUSTICUM, DOLICHOS PRURIENS, FAGOPYRUM ESCULENTUM, GRAPHITES, KALI MURIATICUM, MURIATICUM ACIDUM, OLEANDER, PETROLEUM, PIX LIQUIDA, RADIUM BROMATUM (12X, 30X, 1LM), RHUS TOX, SELENIUM METALLICUM, SULPHUR AND URTICA URENS. | King Bio Inc. | d139d2f1-0369-4963-9f3d-c4cc0f1ea2dd | 2026-03-10 | Warnings | QTT17582CB |
| levofloxacin | LEVOFLOXACIN | Redpharm Drug | 44f31105-5fc9-43d4-e063-6294a90a510f | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| levofloxacin | LEVOFLOXACIN | REMEDYREPACK INC. | 264a3f71-f23e-45e3-926a-421bcccf4e3d | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Additive Formula 3 | DEXTROSE MONOHYDRATE, TRISODIUM CITRATE DIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, CITRIC ACID MONOHYDRATE, AND ADENINE | Terumo BCT, Ltd | 9a5247a1-cc05-442d-b2d0-950f887f03c2 | 2026-01-30 | Warnings, Adverse reactions | LX22YL083G |
| levofloxacin | LEVOFLOXACIN | Preferred Pharmaceuticals Inc. | 7a12135e-cbad-4fe1-98f7-53c41d1f2a21 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 6GNT3Y5LMF |
| Lidocaine Hydrochloride and Dextrose | LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE | ProPharma Distribution | 48c0ee87-f722-1a71-e063-6394a90a72d1 | 2026-01-19 | Warnings, Adverse reactions | LX22YL083G |
| Lidocaine Hydrochloride and Dextrose | LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE | B. Braun Medical Inc. | 7dff29d9-522d-40eb-a9d9-42377912d640 | 2026-01-14 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.